Freiburg-based bicycle leasing specialist JobRad Group completed the acquisition of MyBikePlan, a Swiss Swiss e-commerce and mobility startup focused on e-bikes. In connection with the deal, Walder Wyss advised JobRad Group, while CMS Switzerland represented
Tags :Robert von Rosen
Globally active biopharmaceutical company AstraZeneca has exercised an option to acquire obesity drug startup SixPeaks Bio. In connection with the deal, Lenz & Staehelin represented AstraZeneca, while Walder Wyss advised SixPeaks Bio and its shareholders.
Walder Wyss advised Fielmann Group and tele-ophthalmology platform Ocumeda, as the the first agreed to sell a 10% stake in Ocumenda to Zeiss Vision Care. The deal implied a total company valuation of EUR 100m, with
Walder Wyss advised the Dec Group – a specialist in high-containment processing technologies for the pharmaceutical, chemical, and specialty industries – and its existing shareholders, throughout completion of a financial partnership with ICG, an alternative asset manager
Walder Wyss advised the investors in Mosanna Therapeutics’ Series A financing round EQT Life Sciences and Pivotal bioVenture Partners led the round in question, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning
Walder Wyss advised American translation and language services company TransPerfect throughout its acquisition of Apostroph Group, a Switzerland- and Germany-based language service provider (LSP). The context In connection with the deal, TransPerfect expands its yet
Walder Wyss advised Anklin, a Swiss distributor medical instruments and devices, in transaction that brought the company to become part of German Karl Storz. The parties Reinach-based Anklin is active in the distribution a distributor
Axalta Coating Systems Group has completed the acquisition of André Koch, a well-established provider of car repair and maintenance services. André Koch, previously privately owned, has excelled in the premium segment of the refinish market
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
Coopers Group, a Swiss personnel service provider in the field of professional and executive search, has successfully acquired Zurich-based iET Group, which draws on many years of expertise in recruitment processes. This strategic acquisition is
